Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title Sort ascending
Grant Type
Focus Area
Country
Application Due Date
Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Ghana
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Spain
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Efforts to Improve Quality of Migraine Medical Care
Release Date:
Partner: The Japanese Headache Society
Review Process: Expert Review Panel
Translation: Japanese (link)
Education Internal Medicine Japan
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Addressing Knowledge Gaps in Aplastic Anemia
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Title Sort ascending
Grant Type
Focus Area
Country
Application Due Date
QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF)
Release Date:
Review Process:
Providing Access to Learning Resources for Nurses in Africa
Release Date:
Review Process:
Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEing
Release Date:
Review Process:
Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys
Release Date:
Review Process: Pfizer Internal
Education Hospital Albania
NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care
Release Date:
Review Process:
Patient Registries In Metastatic Breast Cancer
Release Date:
Review Process:
Patient Registries In ATTR-CM
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Japan
Patient Decision Aids for Inflammatory Conditions
Release Date:
Review Process:
Optimizing Menopausal Symptom Management in Canada
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Canada
NSCLC – Current Practice Considerations
Release Date:
Review Process: Pfizer Internal
Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom
Enzalutamide in the Treatment of Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network, Astellas
Review Process: Expert Review Panel
Research Oncology USA
Management of Atopic Dermatitis – International Developed Markets
Release Date:
Review Process: